Jorge Lopez Benitez

Jorge Lopez Benitez

Auto-generated profile, based on publicly available information

Jorge Lopez Benitez

Ministerio de Salud Pública y Bienestar Social, Programa Ampliado de Inmunizaciones Paraguay. Asunción, Paraguay

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2000 in The Journal of Pediatrics
Verified
Journal Article
Open access
PMPaul McCarthy
Paul McCarthy
KFKimberly Freudigman
Kimberly Freudigman
DCDomenic Cicchetti
Domenic Cicchetti
LMLinda Mayes
Linda Mayes
JBJorge Lopez Benitez
Jorge Lopez Benitez
RLRobert LaCamera
Robert LaCamera
For acutely ill children living in less than optimal environments, mothers and pediatricians may have a heightened perception of illness severity, a lower specificity of clinical judgments, and a tendency to over-utilize resources. We examined the mother-child interaction in order to understand the relation of less optimal environments to clinical judgment and resource use.At the 2-week and 6-, 15-, and 24-month well child visits of 316 children, the mother-well child interaction was assessed by using the Biringen's Emotional Availability Scales (EAS). Data were gathered regarding maternal depression and sense of competence, infant temperament, maternal social support, life events, the home environment, and demographics. At ill visits, the mother-ill child interaction was assessed by using the EAS, and mothers and pediatricians independently assessed illness severity using the Acute Illness Observation Scales. Resource use during the illness was evaluated.One thousand nine hundred eight-three acute illnesses were assessed. A less optimal mother-child interaction was significantly (P <.05 for all comparisons) associated with poorer reliability of mothers' judgments, lower specificity of mothers' judgments (71% vs 85%) and pediatricians' judgments (92% vs 97%), and greater use of resources (eg, for hospitalizations, 2.6% of visits vs 0.7%). Adverse maternal, infant, and demographic characteristics were associated with a less optimal mother-well child (r = 0.68) and mother-ill child (r = 0.80) interaction, a heightened perception of illness severity, and greater resource use.Less optimal environments adversely affect the mother-child interaction; a poor mother-child interaction is correlated with low specificity of clinical judgment and over-utilization of resources.

31 August 2024 in Pediatría (Asunción)
Verified
Journal Article
Open access
PDF file
SYSoraya Araya Yampey
Soraya Araya Yampey
JBJorge López Benitez
Jorge López Benitez
LSLuis Cousirat Sanabria
Luis Cousirat Sanabria
RMRocío Britos Martínez
Rocío Britos Martínez
HLHéctor Castro Leguizamón
Héctor Castro Leguizamón
JAJulio Nissen Abente
Julio Nissen Abente
Introducción: A nivel mundial, el cáncer de cuello uterino es el cuarto cáncer más frecuente en la mujer. Objetivo: Describir las coberturas anuales de vacunación contra VPH y ESAVI. Material y Métodos: Estudio observacional descriptivo transversal, realizado en Paraguay, periodo 2013-2023, variables analizadas: coberturas de vacunación contra VPH en niñas de 10 años, según esquema: 3 dosis (2013-2016), 2 dosis (2017-2023), coberturas de vacunación de seguimiento a los 15 años (1ª dosis y Dosis Final), ESAVI grave y no grave. Resultados: Los intervalos de coberturas de vacunación contra VPH 1ª dosis: 55-73% (periodo no pandémico), 33-53 % (periodo pandémico), mientras que para Dosis Final: 1-64% (periodo prepandémico) y 5-31 % (periodo pandémico). Al analizar las coberturas de vacunación contra VPH Dosis Final según esquema el promedio de deserción fue mayor en esquema de 3 dosis: 42 vs 25% (valor p= 0,001). El intervalo de coberturas de seguimiento a los 15 años Dosis Final: 66 a 77%. Hubo un recupero importante en los años 2019-2021: 71%, 65% y 59% respectivamente. La Tasa de ESAVI: 2,5 x 100.000 dosis administradas. Conclusión: Las coberturas de vacunación de seguimiento a los 15 años fueron < 90%. La tasa de ESAVI por 100.000 fue baja.

1 July 2012 in European Journal of Cancer
Verified
Journal Article
Closed access
MKMarta Kamieniak
Marta Kamieniak
IMI. Muñoz-Repeto
I. Muñoz-Repeto
JGJesus García-Donas
Jesus García-Donas
LRL. Robles
L. Robles
TCTeresa Ramon y Cajal
Teresa Ramon y Cajal
MGM.J. García
M.J. García